NSD 644

Drug Profile

NSD 644

Alternative Names: NSD-644

Latest Information Update: 02 Feb 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NeuroSearch
  • Developer GlaxoSmithKline; NeuroSearch
  • Class Analgesics; Neuropsychotherapeutics
  • Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued CNS disorders; Neuropathic pain

Most Recent Events

  • 29 Jan 2009 Discontinued - Phase-I for CNS disorders in Germany (unspecified route)
  • 29 Jan 2009 Discontinued - Phase-I for Neuropathic pain in Germany (unspecified route)
  • 03 Dec 2007 Phase-I clinical trials in CNS disorders in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top